Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Recently listed medtech Singular Health Group (SHG) has signed a binding agreement to acquire Virtual Surgical Planning Software to integrate into its existing MedVR software
  • Virtual Surgical’s solution enables surgeons to manipulate computer aided design (CAD) files to assist in planning facial surgery in virtual reality, ahead of the operation
  • Additionally, CAD company Lyka Smith will purchase 50 licences of integrated software for maxillofacial planning at $300 per licence per month
  • Finally, Singular Health will invest $300,000 for a 25-per-cent equity stake in Australia Additive Engineering, which will also lease the company polymer and titanium 3D printers
  • SHG closed 6.5 per cent lower at 65 cents per share

Singular Health Group (SHG) has signed a binding agreement to acquire Virtual Surgical Planning Software to integrate into its existing MedVR software.

Virtual Surgical’s solution enables surgeons to manipulate computer aided design (CAD) files to assist in planning maxillofacial facial surgery in virtual reality, ahead of the operation.

The company listed on the ASX in early February 2021 and, as such, is required to obtain shareholder approval for the acquisition to go ahead.

Assuming shareholders give the go-ahead, the virtual software planning solution is expected to be integrated with the MedVR software within the following three months.

Upon the integration, CAD company Lyka Smith will purchase 50 licences of integrated software for maxillofacial planning from Singular Health at $300 per licence per month.

Finally, Singular Health will invest $300,000 in Australia Additive Engineering for a 25 per cent equity stake in the Melbourne-based 3D printing company.

Australia Additive Energy will also lease Singular Health polymer and titanium 3D printers which it will use to manufacture cranio-facial surgical guides and personalised fixment plates.

SHG closed 6.5 per cent lower at 65 cents.

SHG by the numbers
More From The Market Herald

" Race Oncology (ASX:RAC) reports $1.8m in cash outflows

Race Oncology (ASX:RAC) reports $1.8 million in cash outflows
Imugene (ASX:IMU) - CEO, Leslie Chong

" Imugene (ASX:IMU) signs clinical trial agreement with Roche for lung cancer

Imugene (ASX:IMU) signs a clinical trial supply agreement with Roche to evaluate the combination of treatments…
Fiji Kava (ASZ:FIJ) - CEO and Managing Director, Dr Anthony Noble

" Fiji Kava (ASX:FIJ) hits quarterly revenue record

Fiji Kava (ASX:FIJ) has tabled a record quarterly revenue of $476,531 for the December quarter, up…